Basic Information
| LncRNA/CircRNA Name | ANRIL |
| Synonyms | CDKN2B-AS1, ANRIL, CDKN2B-AS, CDKN2BAS, NCRNA00089, PCAT12, p15AS |
| Region | GRCh38_9:21994778-22121097 |
| Ensemble | ENSG00000240498 |
| Refseq | NR_003529 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR, RNAi, Western blot etc. |
| Sample | thyroid cancer tissues, cell lines (K1, TPC-1, SW579 and Nthy-ori 3-1) |
| Expression Pattern | up-regulated |
| Function Description | The results of qRT-PCR showed significantly higher expression of ANRIL mRNA in the TC tissues relative to the adjacent normal tissues. ANRIL may reduce p15INK4B expression through inhibiting TGF-B/Smad signaling pathway, promoting invasion and metastasis of TC cells, and the silencing of ANRIL inhibits the invasion and metastasis of TPC-1 cells. |
| Pubmed ID | 27507052 |
| Year | 2016 |
| Title | Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-B/Smad signaling pathway. |
External Links
| Links for ANRIL | GenBank HGNC NONCODE |
| Links for thyroid cancer | OMIM COSMIC |